-
1
-
-
10744230122
-
Implications of upstream glycoprotein IIIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: A comparison of the Thrombolysis in Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial
-
Sabatine MS, Morrow DA, Giugliano RP, Murphy SA, Demopoulos LA, DiBattiste PM, Weintraub WS, McCabe CH, Antman EM, Cannon CP, Brawnwald E. Implications of upstream glycoprotein IIIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial. Circulation. 2004;109:874-880.
-
(2004)
Circulation
, vol.109
, pp. 874-880
-
-
Sabatine, M.S.1
Morrow, D.A.2
Giugliano, R.P.3
Murphy, S.A.4
Demopoulos, L.A.5
DiBattiste, P.M.6
Weintraub, W.S.7
McCabe, C.H.8
Antman, E.M.9
Cannon, C.P.10
Brawnwald, E.11
-
2
-
-
0035804846
-
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACLE study: A randomized controlled trial
-
Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, Zeiher A, Chaitman BR, Leslie S, Stern T. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACLE study: A randomized controlled trial. JAMA. 2001;285:1711-1718.
-
(2001)
JAMA
, vol.285
, pp. 1711-1718
-
-
Schwartz, G.G.1
Olsson, A.G.2
Ezekowitz, M.D.3
Ganz, P.4
Oliver, M.F.5
Waters, D.6
Zeiher, A.7
Chaitman, B.R.8
Leslie, S.9
Stern, T.10
-
3
-
-
27744603499
-
High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: The IDEAL study: a randomized controlled trial
-
Pedersen TR, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Holme I, Larsen ML, Bendiksen FS, Lindahl C, Szarek M, Tsai J. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA. 2005;294:2437-2445.
-
(2005)
JAMA
, vol.294
, pp. 2437-2445
-
-
Pedersen, T.R.1
Faergeman, O.2
Kastelein, J.J.3
Olsson, A.G.4
Tikkanen, M.J.5
Holme, I.6
Larsen, M.L.7
Bendiksen, F.S.8
Lindahl, C.9
Szarek, M.10
Tsai, J.11
-
4
-
-
27444433900
-
Prospects for personalized cardiovascular medicine: The impact of genomics
-
Ginsburg GS, Donahue MP, Newby LK. Prospects for personalized cardiovascular medicine: the impact of genomics. J Am Coll Cardiol. 2005;46:1615-1627.
-
(2005)
J Am Coll Cardiol
, vol.46
, pp. 1615-1627
-
-
Ginsburg, G.S.1
Donahue, M.P.2
Newby, L.K.3
-
5
-
-
0027192359
-
Comparison of coronary angiographic findings in acute and chronic first presentation of ischemic heart disease
-
Bogaty P, Brecker SJ, White SE, Stevenson RN, El-Tamimi H, Balcon R, Maseri A. Comparison of coronary angiographic findings in acute and chronic first presentation of ischemic heart disease. Circulation. 1993;87:1938-1946.
-
(1993)
Circulation
, vol.87
, pp. 1938-1946
-
-
Bogaty, P.1
Brecker, S.J.2
White, S.E.3
Stevenson, R.N.4
El-Tamimi, H.5
Balcon, R.6
Maseri, A.7
|